Cargando…

Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use

INTRODUCTION: Hypoxic tumor microenvironment (TME) is the major contributor to cancer metastasis, resistance to chemotherapy, and recurrence of tumors. So far, no approved treatment has been available to overcome tumor hypoxia. OBJECTIVES: The present study aimed to relieve tumor hypoxia via a nanoz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veroniaina, Hanitrarimalala, Wu, Zhenghong, Qi, Xiaole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463960/ https://www.ncbi.nlm.nih.gov/pubmed/34603790 http://dx.doi.org/10.1016/j.jare.2021.02.004

Ejemplares similares

Synthesis and compatibility evaluation of versatile mesoporous silica nanoparticles with red blood cells: an overview
por: Mukhopadhyay, Subhankar, et al.
Publicado: (2019)

Nanozymes in Tumor Theranostics
por: Ma, Qiulian, et al.
Publicado: (2021)

Applications and developments of gene therapy drug delivery systems for genetic diseases
por: Pan, Xiuhua, et al.
Publicado: (2021)

Dual-targeting nanozyme for tumor activatable photo-chemodynamic theranostics
por: Chen, Chaoyi, et al.
Publicado: (2022)

Nanozyme-based catalytic theranostics
por: Zhang, Yanan, et al.
Publicado: (2019)

Ferritins as natural and artificial nanozymes for theranostics
por: Jiang, Bing, et al.
Publicado: (2020)

Hypoxia-active nanoparticles used in tumor theranostic
por: Wang, Yaqin, et al.
Publicado: (2019)

Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes
por: Yang, Lu, et al.
Publicado: (2023)

Emerging two-dimensional material nanozymes for theranostic nanomedicine
por: You, Yanling, et al.
Publicado: (2021)

Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
por: Juliana, Fidiniaina Rina, et al.
Publicado: (2019)

In situ synthesized nanozyme for photoacoustic-imaging-guided photothermal therapy and tumor hypoxia relief
por: Chen, Chaoyi, et al.
Publicado: (2023)

Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment
por: Krishnamachary, Balaji, et al.
Publicado: (2020)

A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy
por: Fan, Jing Hao, et al.
Publicado: (2019)

Drug Delivery Strategies and Nanozyme Technologies to Overcome Limitations for Targeting Oxidative Stress in Osteoarthritis
por: Aldrich, Jessica Lee, et al.
Publicado: (2023)

Nanozyme for tumor therapy: Surface modification matters
por: Tang, Guoheng, et al.
Publicado: (2021)

Targeted Theranostic Nanoparticles for Brain Tumor Treatment
por: Mendes, Maria, et al.
Publicado: (2018)

Theranostic Probes for Targeting Tumor Microenvironment: An Overview
por: Sikkandhar, Musafar Gani, et al.
Publicado: (2017)

Tumor-derived covalent organic framework nanozymes for targeted chemo-photothermal combination therapy
por: Zhou, Shengnan, et al.
Publicado: (2023)

Nanozymes—Hitting the Biosensing “Target”
por: Wu, Yingfen, et al.
Publicado: (2021)

Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome
por: Kim, Jae-Young, et al.
Publicado: (2017)

Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers
por: Beztsinna, Nataliia, et al.
Publicado: (2017)

Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
por: Lin, Gan, et al.
Publicado: (2016)

Neuroendocrine tumor theranostics
por: Ichikawa, Yasushi, et al.
Publicado: (2022)

Nanoprobes for Tumor Theranostics
por: Zhu, Jiaoyang, et al.
Publicado: (2022)

Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
por: Graham, Kaitlin, et al.
Publicado: (2018)

Smart biomaterials for enhancing cancer therapy by overcoming tumor hypoxia: a review
por: Salim, Samar A., et al.
Publicado: (2022)

Advancing theranostics with tumor-targeting peptides for precision otolaryngology
por: Wright, Chadwick L., et al.
Publicado: (2016)

Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
por: Wang, Dongdong, et al.
Publicado: (2020)

A Sub-Nanostructural Transformable Nanozyme for Tumor Photocatalytic Therapy
por: Hu, Xi, et al.
Publicado: (2022)

Progress toward overcoming hypoxia-induced resistance to solid tumor therapy
por: Karakashev, Sergey V, et al.
Publicado: (2015)

Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia
por: Li, Juanjuan, et al.
Publicado: (2023)

Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
por: Choi, Moon Jung, et al.
Publicado: (2023)

Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
por: Tang, Yufu, et al.
Publicado: (2022)

Macrophage-Encapsulated Bioorthogonal Nanozymes for Targeting Cancer Cells
por: Das, Riddha, et al.
Publicado: (2022)

Visualization nanozyme based on tumor microenvironment “unlocking” for intensive combination therapy of breast cancer
por: Wang, Zhiyi, et al.
Publicado: (2020)

In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy
por: Fan, Kelong, et al.
Publicado: (2018)

Engineering Circulating Tumor Cells as Novel Cancer Theranostics
por: Parkins, Katie M, et al.
Publicado: (2020)

Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
por: McDonald, Paul C., et al.
Publicado: (2016)

Applications of Functionalized Fullerenes in Tumor Theranostics
por: Chen, Zhiyun, et al.
Publicado: (2012)

Nanomaterials for the regulation of the tumor microenvironment and theranostics
por: Zhen, Wenyao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0f19fe93csr2ov9ld9al04rbmd